The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 2,601–2,800 of 3,517
Chagraoui, A., Protais, P., Filloux, T., & Mocaër, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1465-3 · Cited by 60
Barak, Y., Mirecki, I., Knobler, H. Y., Natan, Z., & Aizenberg, D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1801-2 · Cited by 60
Feige, B., Voderholzer, U., Riemann, D. W., Dittmann, R., Hohagen, F., & Berger, T. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00314-1 · Cited by 60
Nikulina, E. M., Miczek, K. A., & Hammer, R. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300658 · Cited by 60
Beasley, C. L., COTTER, D., & Everall, I. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00376-0 · Cited by 60
Millan, M. J., Brocco, M., Papp, M., Serres, F., Rochelle, C. D. L., Sharp, T., Péglion, J.-L., & Dekeyne, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062463 · Cited by 60
Self-citationMelatonin: Therapeutic Use in Sleep Disorders
Chase, J. E., & Gidal, B. E. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703101015 · Cited by 60
Tuma, J., Strubbe, J. H., Mocaër, E., & Koolhaas, J. M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.02.004 · Cited by 60
Halfenny, D. M., Callado, L. F., Hopwood, S. E., Bamigbade, T. A., Langford, R. M., & Stamford, J. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/83.6.909 · Cited by 60
Potential antidepressant activity of sigma ligands.
Skuza, G. (2003) · PubMed · Cited by 60
Galantamine: a review of its use in Alzheimer's disease and vascular dementia.
Corey‐Bloom, J. (2003) · PubMed · Cited by 60
Affective Disorders and Circadian Rhythms
Hallonquist, J. D., Goldberg, M. A., & Brandes, J. S. (1986) · The Canadian Journal of Psychiatry · doi:10.1177/070674378603100315 · Cited by 60
McClellan, K. J., & Scott, L. J. (2003) · Drugs · doi:10.2165/00003495-200363110-00007 · Cited by 60
Bschor, T., Lewitzka, U., Sasse, J., Adli, M., Köberle, U., & Bauer, M. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45135 · Cited by 59
Chemineau, P., Daveau, A., Pelletier, J., Malpaux, B., Karsch, F. J., & Viguié, C. (2003) · BMC Neuroscience · doi:10.1186/1471-2202-4-1 · Cited by 59
Neural network analysis in pharmacogenetics of mood disorders
Serretti, A., & Smeraldi, E. (2004) · BMC Medical Genetics · doi:10.1186/1471-2350-5-27 · Cited by 59
Śmiałowska, M., Szewczyk, B., Brański, P., Wierońska, J. M., Pałucha-Poniewiera, A., Bajkowska, M., & Pilc, A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00062-x · Cited by 59
Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats
Carlezon, W. A., Rohan, M. L., Mague, S. D., Meloni, E. G., Parsegian, A., Cayetano, K. R., Tomasiewicz, H. C., Rouse, E. D., Cohen, B. M., & Renshaw, P. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.011 · Cited by 59
Rénéric, J.-P., Bouvard, M., & Stinus, L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00214-1 · Cited by 59
Jutkiewicz, E. M., Rice, K. C., Woods, J. H., & Winsauer, P. J. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200311000-00003 · Cited by 59
Sante, A. B., Nobre, M. J., & Brandão, M. L. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200011000-00005 · Cited by 59
Paroxetine-Induced Increase in Metabolic End Products of Nitric Oxide
Lara, N., Archer, S. L., Baker, G. B., & Mellédo, J. L. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000085416.08426.1d · Cited by 59
Novel strategies for pharmacotherapy of depression
Maubach, K. A., Rupniak, N. M. J., Kramer, M. S., & Hill, R. G. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80070-2 · Cited by 59
Gray, J. A., & Green, A. R. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb11331.x · Cited by 59
Serotonin and human information processing: fluvoxamine can improve reaction time performance
Hasbroucq, T., Rihet, P., Blin, O., & Possamaï, C.-A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00451-5 · Cited by 59
Pharmaceutical approaches to the treatment of obesity
Jandacek, R. J., & Woods, S. C. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03244-1 · Cited by 59
An Exponential Core in the Heart of the Yeast Protein Interaction Network
Pereira‐Leal, J. B., Audit, B., Peregrín-Alvarez, J. M., & Ouzounis, C. (2004) · Molecular Biology and Evolution · doi:10.1093/molbev/msi024 · Cited by 59
Risso, F., Parodi, M., Grilli, M., Molfino, F., Raiteri, M., & Marchi, M. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00173-6 · Cited by 59
Rojas-Corrales, M. O., Berrocoso, E., Gibert‐Rahola, J., & Micó, J. A. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800305 · Cited by 59
The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors
Siuciak, J. A., & Fujiwara, R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1809-7 · Cited by 59
Reduction in Acetylcholine Release in the Hippocampus of Dopamine D5 Receptor-Deficient Mice
Laplante, F., Sibley, D. R., & Quirion, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300467 · Cited by 58
Treatment issues related to sleep and depression.
Thase, M. E. (2000) · PubMed · Cited by 58
Antidepressants : new pharmacological strategies
Skolnick, P. (1997) · Humana Press eBooks · Cited by 58
Presgraves, S. P., Borwege, S., Millan, M. J., & Joyce, J. N. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.06.021 · Cited by 58
Self-citationIllés, P., Finta, E. P., & Nieber, K. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00173217 · Cited by 58
Roh, M., Kang, U. G., Shin, S. Y., Lee, Y. H., Jung, H. Y., Juhnn, Y.-S., & Kim, Y. S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00307-x · Cited by 58
Genetic manipulations of GABAA receptor in mice make inhibition exciting
Vicini, S., & Ortinski, P. I. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.001 · Cited by 58
Gobert, A., Billiras, R., Cistarelli, L., & Millan, M. J. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.04.040 · Cited by 58
Self-citationChronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats
Yamauchi, M., Tatebayashi, T., Nagase, K., Kojima, M., & Imanishi, T. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.05.003 · Cited by 58
Gatch, M. B. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00422-3 · Cited by 58
Lee, M. D., Somerville, E. M., Kennett, G. A., Dourish, C. T., & Clifton, P. G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1864-0 · Cited by 58
Ondansetron improves cognitive performance in the Morris water maze spatial navigation task
Fontana, D., Daniels, S. E., Henderson, C., Eglen, R. M., & Wong, E. H. F. (1995) · Psychopharmacology · doi:10.1007/bf02245812 · Cited by 58
Marchetti, E., Chaillan, F. A., Dumuis, A., Bockaert, J., Soumireu-Mourat, B., & Roman, F. S. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.033 · Cited by 58
Time course of depression-symptom improvement during treatment with duloxetine
Hirschfeld, R. M. A., Mallinckrodt, C. H., Lee, T. C., & Detke, M. J. (2005) · Depression and Anxiety · doi:10.1002/da.20071 · Cited by 58
Mahajan, T., Crown, A. L., Checkley, S. A., Farmer, A. D., & Lightman, S. L. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510325 · Cited by 58
S-nitrosothiols inhibit neuronal norepinephrine transport
Kaye, D. M., Wiviott, S. D., Kobzik, L., Kelly, R. A., & Smith, T. W. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.2.h875 · Cited by 58
Peptide-binding G protein-coupled receptors: new opportunities for drug design
Gurrath, M. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013371798 · Cited by 57
Weikop, P., Kehr, J., & Scheel-Krüger, J. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800311 · Cited by 57
Fujihara, H., Sei, H., Morita, Y., Ueta, Y., & Morita, K. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:21:3:223 · Cited by 57
Neurotransmitter-like Actions of L-DOPA
Misu, Y., Ueda, H., & Goshima, Y. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61019-4 · Cited by 57
Antiparkinsonian and antidepressant effects of high doses of bromocriptine
Jouvent, R., ABENSOUR, P., Bonnet, A. M., Widlöcher, D., Agid, Y., & Lhermitte, F. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90006-x · Cited by 57
Oligomer formation by Na+–Cl−-coupled neurotransmitter transporters
Sitte, H. H., & Freissmuth, M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.072 · Cited by 57
Acute low doses of melatonin restore full sexual activity in impotent male rats
Drago, F., & Busă, L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02715-3 · Cited by 57
Invernizzi, R. W., Pozzi, L., Garattini, S. K., & SAMANIN, R. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90171-k · Cited by 57
Motivational Symptoms of Depression Mask Preclinical Alzheimer’s Disease in Elderly Subjects
Bartolini, M., Coccia, M., Luzzi, S., Provinciali, L., & Ceravolo, M. G. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080968 · Cited by 57
Thyroid hormone distribution in the mouse brain: the role of transthyretin
Palha, J. A., Nissanov, J., Fernandes, R., Sousa, J. C., Bertrand, L., Dratman, M. B., de Escobar, G. M., Gottesman, M. E., & Saraiva, M. J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00228-2 · Cited by 57
Denys, D. A. J. P., Klompmakers, A. A., & Westenberg, H. G. M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1880-0 · Cited by 57
Six-month course of mild cognitive impairment and affective symptoms in late-life depression
Adler, G., Chwalek, K., & Jajcevic, A. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.09.003 · Cited by 57
Is psychotherapy an effective treatment for melancholia and other severe depressive states?
Thase, M. E., & Friedman, E. S. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00033-6 · Cited by 57
Novel detection strategies for drug discovery
Hemmilä, I. A., & Hurskainen, P. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02390-5 · Cited by 57
Neuronal Nicotinic Receptor and Psychiatric Disorders: Functional and Behavioral Effects of Nicotine
Araki, H., Suemaru, K., & Gomita, Y. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.88.133 · Cited by 57
Gonzales, C., Voirol, M., Giacomini, M., Gaillard, R. C., Pedrazzini, T., & Pralong, F. P. (2003) · The FASEB Journal · doi:10.1096/fj.03-0189fje · Cited by 57
Meneses, A. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1021800822997 · Cited by 57
Dopaminergic influences on male rat sexual behavior
Hull, E. M. (1995) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529832.012 · Cited by 56
Andreoli, V. M., Caillard, V., Deo, R., RYBAKOWSKI, J. K., & Versiani, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00010 · Cited by 56
Steinacher, L., Vandel, P., ZULLINO, D. F., Eap, C. B., Brawand-Amey, M., & Baumann, P. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00018-4 · Cited by 56
Tachykinin receptors in gastrointestinal motility
Holzer‐Petsche, U. (1995) · Regulatory Peptides · doi:10.1016/0167-0115(95)00019-8 · Cited by 56
Metyrapone displays antidepressant-like properties in preclinical paradigms
Healy, D. G., Harkin, A., Cryan, J. F., Kelly, J. P., & Leonard, B. E. (1999) · Psychopharmacology · doi:10.1007/s002130051062 · Cited by 56
Differential hormonal regulation of tryptophan hydroxylase-2 mRNA in the murine dorsal raphe nucleus
Clark, J. A., Pai, L.-Y., Flick, R. B., & Rohrer, S. P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.013 · Cited by 56
Seager, M. A., Barth, V., Phebus, L. A., & Rasmussen, K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2198-2 · Cited by 56
Dominant Negative Isoform of Rat Norepinephrine Transporter Produced by Alternative RNA Splicing
Kitayama, S., Ikeda, T., Mitsuhata, C., Sato, T., Morita, K., & Dohi, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10731 · Cited by 56
Measurement of Anxiety in Transgenic Mice
Weiss, S. Μ., Lightowler, S., Stanhope, K. J., Kennett, G. A., & Dourish, C. T. (2000) · Reviews in the Neurosciences · doi:10.1515/revneuro.2000.11.1.59 · Cited by 56
Gasbarri, A., Introini-Collison, I. B., Packard, M. G., Pacitti, C., & McGaugh, J. L. (1993) · Brain Research · doi:10.1016/0006-8993(93)90750-h · Cited by 56
Neurochemical and Psychotropic Effects of Bupropion in Healthy Male Subjects
Gobbi, G., Slater, S., Boucher, N., Debonnel, G., & Blier, P. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084023.22282.03 · Cited by 56
McMillan, C., Bradley, C., Gibney, J., Healy, M. L., Russell-Jones, D. L., & Sönksen, P. H. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01870.x · Cited by 56
Prevalence and Correlates of Depression in a Population of Nonagenarians
Forsell, Y., Jorm, A. F., Strauss, E. I. V., & Winblad, B. G. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.1.61 · Cited by 56
Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?
Taché, Y. (2004) · Gut · doi:10.1136/gut.2003.036400 · Cited by 56
Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices
Hennings, E. C. P., Kiss, J. P., & Vizi, E. S. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00343-0 · Cited by 55
Central GABAergic Systems and Depressive Illness
Tunnicliff, G., & Malatyńska, E. (2003) · Neurochemical Research · doi:10.1023/a:1023287729363 · Cited by 55
Complex-trait genetics: emergence of multivariate strategies
Phillips, T. J., & Belknap, J. K. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn847 · Cited by 55
Gartside, S. E., Clifford, E. M., Cowen, P. J., & Sharp, T. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702546 · Cited by 55
Lüttgen, M., Ögren, S. O., & Meister, B. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.09.001 · Cited by 55
Weibel, L., Turek, F. W., Mocaër, E., & Reeth, O. V. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02806-7 · Cited by 55
Rittenhouse, P. A., Levy, A. D., Li, Q., Bethea, C. L., & de Kar, L. D. V. (1993) · Endocrinology · doi:10.1210/endo.133.2.8344205 · Cited by 55
Lewis, M. E., Khachaturian, H., & Watson, S. J. (1985) · Peptides · doi:10.1016/0196-9781(85)90010-5 · Cited by 55
Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia
Newcomer, J. W., Faustman, W. O., Yeh, W., & Csernansky, J. G. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90093-k · Cited by 55
Rascati, K. L. (1995) · Clinical Therapeutics · doi:10.1016/0149-2918(95)80055-7 · Cited by 55
Minireview: Diversity and Complexity of Signaling through Peptidergic G Protein-Coupled Receptors
Rashid, A. J., O’Dowd, B. F., & George, S. R. (2004) · Endocrinology · doi:10.1210/en.2004-0052 · Cited by 55
Quality of life and function after electroconvulsive therapy
McCall, W. V., Dunn, A. G., & Rosenquist, P. B. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.185.5.405 · Cited by 55
Kirchheiner, J., Bertilsson, L., Bruus, H., Wolff, A., Roots, I., & Bauer, M. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45136 · Cited by 55
Thase, M. E., Rush, A. J., Manber, R., Kornstein, S. G., Klein, D. N., Markowitz, J. C., Ninan, P. T., Friedman, E. S., Dunner, D. L., Schatzberg, A. F., et al. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0605 · Cited by 54
Genetic polymorphisms of serotonin and dopamine transporters in mental disorders.
Ueno, S. (2003) · PubMed · Cited by 54
Serotonin 5-HT1A Agonists: A Comparative Review
Pecknold, J. C. (1994) · CNS Drugs · doi:10.2165/00023210-199402030-00007 · Cited by 54
Kalra, S. P., & Kalra, P. S. (2004) · Peptides · doi:10.1016/j.peptides.2004.03.001 · Cited by 54
Michel, M. C., Rother, A., Hiemke, C., & Ghraf, R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90629-0 · Cited by 54
Subchronic Administration of Fluoxetine Impairs Estrous Behavior in Intact Female Rats
Matuszczyk, J. V. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00040-2 · Cited by 54
Chopin, P., Colpaert, F. C., & Marien, M. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.187 · Cited by 54
Potentiation of Antidepressants with Lithium or Carbamazepine in Treatment-Resistant Depression
RYBAKOWSKI, J. K., Suwalska, A., & Chłopocka-Woźniak, M. (1999) · Neuropsychobiology · doi:10.1159/000026610 · Cited by 54
Enantioselective behavioral effects of sibutramine metabolites
Glick, S. D., Haskew-Layton, R. E., Maisonneuve, I. M., Carlson, J. N., & Jerussi, T. P. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00216-8 · Cited by 54
Cohen, R. M., Aulakh, C. S., Campbell, I. C., & Murphy, D. L. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90614-8 · Cited by 54
Antidepressant Medication Change in a Clinical Treatment Setting
Nurnberg, H. G., Thompson, P. M., & Hensley, P. L. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0902 · Cited by 54
Fluvoxamine as an Adjunctive Agent in Schizophrenia
Silver, H. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00200.x · Cited by 54
Duncan, M. J., Grear, K. E., & Hoskins, M. A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.025 · Cited by 54
Altieri, M., Marini, F., Arban, R., Vitulli, G., & Jansson, B. O. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.028 · Cited by 54
Matuszewich, L., Lorrain, D. S., Trujillo, R., Dominguez, J. M., Putnam, S. K., & Hull, E. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01331-6 · Cited by 54
Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies
Brannan, S. K., Mallinckrodt, C. H., Detke, M. J., Watkin, J. G., & Tollefson, G. D. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.05.005 · Cited by 54
Antidepressant Treatment of Psychotic Major Depression: Potential Role of the σ Receptor
Stahl, S. M. (2005) · CNS Spectrums · doi:10.1017/s1092852900022641 · Cited by 54
Lelas, S., Wong, H., Li, Y.-W., Heman, K. L., Ward, K. A., Zeller, K. L., Sieracki, K. K., Polino, J. L., Godonis, H. E., Ren, S. X., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058784 · Cited by 54
Current trends in lead discovery: Are we looking for the appropriate properties?
Oprea, T. I. (2000) · Molecular Diversity · doi:10.1023/a:1021368007777 · Cited by 54
Fluoxetine reduces l-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum
Yamato, H., Kannari, K., Shen, H., Suda, T., & Matsunaga, M. (2001) · Neuroreport · doi:10.1097/00001756-200105080-00015 · Cited by 53
Kooyman, A. R., Zwart, R., Vanderheijden, P. M. L., van Hooft, J. A., & Vijverberg, H. P. M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90081-7 · Cited by 53
Mitchell, P. J., & Redfern, P. H. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00016 · Cited by 53
Tiihonen, J., Kuoppamäki, M., Syvälahti, E. K. G., Någren, K., Eronen, E., Hietala, J. A., & Bergman, J. R. (1996) · Psychopharmacology · doi:10.1007/bf02247377 · Cited by 53
Effect of rapid eye movement sleep deprivation on rat brain monoamine oxidases
Thakkar, M. M., & Mallick, B. N. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90433-g · Cited by 53
Sleep deprivation therapy in depressive illness and parkinson's disease
DeMet, E. M., Chicz-DeMet, A., Fallon, J. H., & Sokolski, K. N. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00039-1 · Cited by 53
Systems biology in neuroscience: bridging genes to cognition
Grant, S. G. (2003) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2003.09.016 · Cited by 53
Agid, O., & Lerer, B. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570200322x · Cited by 53
Altered response to benzodiazepine anxiolytics in mice lacking GABAB(1) receptors
Mombereau, C., Kaupmann, K., van der Putten, H., & Cryan, J. F. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.036 · Cited by 53
Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results
Brunner, J., Keck, M. E., Landgraf, R., Uhr, M., Namendorf, C., & Bronisch, T. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00071-8 · Cited by 53
Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat
Chang, F., & Opp, M. R. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2001 · Cited by 53
Hersi, A., Richard, J., Gaudreau, P., & Quirion, R. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07150.1995 · Cited by 53
Gilmor, M. L., Skelton, K. H., Nemeroff, C. B., & Owens, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045419 · Cited by 53
Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats
Barros, D. M., Izquierdo, L. A., Medina, J. H., & Izquierdo, I. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200205000-00004 · Cited by 53
Adding Risperidone to Selective Serotonin Reuptake Inhibitor Improves Chronic Depression
O’Connor, M., & Silver, H. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199802000-00018 · Cited by 53
Elucidating the antidepressant actions of substance P (NK1 receptor) antagonists.
Rupniak, N. M. J. (2002) · PubMed · Cited by 53
On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
Pałucha-Poniewiera, A., & Pilc, A. (2002) · PubMed · Cited by 53
Tatarczynska, E., Pałucha-Poniewiera, A., Szewczyk, B., Chojnacka-Wójcik, E., Wierońska, J. M., & Pilc, A. (2002) · PubMed · Cited by 53
The localisation of the extraneuronal monoamine transporter (EMT) in rat brain
Haag, C., Berkels, R., Gründemann, D., Lazar, A., Taubert, D., & Schömig, E. (2003) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02180.x · Cited by 52
Melis, M. R., Succu, S., Mascia, M. S., & Argiolas, A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.053 · Cited by 52
Mele, A., Castellano, C., Felici, A., Cabib, S., Caccia, S., & Oliverio, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00266-x · Cited by 52
Barros, D., Ramirez, M., & Izquierdo, I. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2004.10.001 · Cited by 52
Linnér, L., Arborelius, L., Nomikos, G. G., Bertilsson, L., & Svensson, T. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00126-2 · Cited by 52
Gundersen, V., Holten, A. R., & Storm‐Mathisen, J. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.01.017 · Cited by 52
Carvajal, C., Vercauteren, F., Dumont, Y., Michalkiewicz, M., & Quirion, R. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.01.004 · Cited by 52
Herpfer, I., Hunt, S. P., & Stanford, S. C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.016 · Cited by 52
Ihalainen, J. A., & Tanila, H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02691.x · Cited by 52
Anxiolytic profile of ropinirole in the rat, mouse and common marmoset
Rogers, D. C., Costall, B., Domeney, A. M., Gerrard, P. A., Greener, M., Kelly, M. E., Hagan, J. J., & Hunter, A. J. (2000) · Psychopharmacology · doi:10.1007/s002130000485 · Cited by 52
Goshima, Y., Nakamura, S., & Misu, Y. (1990) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.53.47 · Cited by 52
Modulation of cannabinoid agonist binding by 5‐HT in the rat cerebellum
Devlin, M. G., & Christopoulos, A. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00797.x · Cited by 52
Varas, M., Pérez, M. F., Ramírez, O. A., & de Barioglio, S. R. (2003) · Peptides · doi:10.1016/j.peptides.2003.09.006 · Cited by 52
Effects of fluoxetine on wild and mutant neuronal α7 nicotinic receptors
Maggi, L., Palma, E., Miledi, R., & Eusebi, F. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000392 · Cited by 52
Central effect of yohimbine on sexual behavior in the rat
Sala, M., Braida, D., Leone, M. P., Calcaterra, P., Monti, S., & Gori, E. (1990) · Physiology & Behavior · doi:10.1016/0031-9384(90)90057-b · Cited by 52
Rodríguez–Manzo, G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00140-5 · Cited by 52
Kos, T., & Popik, P. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200505000-00004 · Cited by 52
Gulwadi, A. G., Korpinen, C. D., Mailman, R. B., Nichols, D. E., Sit, S., & Taber, M. T. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38751-8 · Cited by 52
Shimizu, M., Nishida, A., Zensho, H., & Yamawaki, S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21318-0 · Cited by 52
Nierenberg, A. A., Quitkin, F. M., Kremer, C., Keller, M. B., & Thase, M. E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300405 · Cited by 51
Switching antidepressants for treatment-resistant major depression.
Marangell, L. B. (2001) · PubMed · Cited by 51
Karkanias, G. B., Li, C.-S., & Etgen, A. M. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00359-x · Cited by 51
Abe, Y., Aoyagi, A., Hara, T., Abe, K., Yamazaki, R., Kumagae, Y., Naruto, S., Koyama, K., Marumoto, S., Tago, K., et al. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.93.95 · Cited by 51
Nuijten, M. J. C., Hardens, M., & Souêtre, E. (1995) · PharmacoEconomics · doi:10.2165/00019053-199508020-00007 · Cited by 51
Guest, P. C., Knowles, M. R., Molon-Noblot, S., Salim, K., Smith, D., Murray, F., Laroque, P., Hunt, S. P., Felipe, C. D., Rupniak, N. M. J., et al. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.064 · Cited by 51
Volkow, N. D., Wang, G., Fowler, J. S., Learned, S. M., Yang, J., Logan, J., Schlyer, D. J., Gatley, J. S., Wong, C., Zhu, W., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.007 · Cited by 51
Goetze, U., & Tölle, R. (2008) · Neuropsychobiology · doi:10.1159/000118414 · Cited by 51
Takamori, K., Yoshida, S., & Okuyama, S. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01279-6 · Cited by 51
Hermann, H., & Lutz, B. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.080 · Cited by 51
Pei, Q., Tordera, R. M., Sprakes, M., & Sharp, T. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.017 · Cited by 51
Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response
Ott, G. E., Rao, U., Lin, K., Gertsik, L., & Poland, R. E. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004298 · Cited by 51
Chronic Stress Effects on Sexual Behavior in Male and Female Rats
Gorzalka, B. B., Hanson, L., & Brotto, L. A. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00106-3 · Cited by 51
Moclobemide: Evolution, Pharmacodynamic, and Pharmacokinetic Properties
Bonnet, U. (2002) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2002.tb00229.x · Cited by 51
Odagaki, Y., Toyoshima, R., & Yamauchi, T. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051526 · Cited by 51
Cs, W., Jm, F., Jl, D., & Heiser, J. F. (1996) · PubMed · Cited by 51
Björklund, M., Sirviö, J., Puoliväli, J. T., Sallinen, J., Jäkälä, P., Scheinin, M., Kobilka, B. K., & Riekkinen, P. J. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.569 · Cited by 51
Murray, J. F., Mercer, J. G., Adan, R. A. H., Datta, J., Aldairy, C., Moar, K. M., Baker, B. I., Stock, M. J., & Wilson, C. A. (2000) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2000.00577.x · Cited by 50
Bunsey, M. D., & Strupp, B. J. (1995) · Behavioral Neuroscience · doi:10.1037//0735-7044.109.5.903 · Cited by 50
Pullar, I. A., Carney, S. L., Colvin, E. M., Lucaites, V. L., Nelson, D. L. G., & Wedley, S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00728-7 · Cited by 50
Shimoyama, N., Shimoyama, M., Davis, A. M., Monaghan, D. T., & Inturrisi, C. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074856 · Cited by 50
Zorrilla, E. P., Schulteis, G., Ormsby, A., Klaassen, A., LING, N. C., McCarthy, J. R., Koob, G. F., & Souza, E. B. D. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03345-0 · Cited by 50
Ago, Y., Nakamura, S., Baba, A., & Matsuda, T. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300567 · Cited by 50
DOI-induced inhibition of copulatory behavior in male rats: Reversal by 5-HT2 antagonists
Watson, N. V., & Gorzalka, B. B. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90135-o · Cited by 50
Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake
López-Valdés, H. E., & García‐Colunga, J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000885 · Cited by 50
Reduced attention in mice overproducing corticotropin-releasing hormone
van Gaalen, M. M., Stenzel‐Poore, M. P., Holsboer, F., & Steckler, T. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00381-9 · Cited by 50
Sprouse, J. S., Li, X., Stock, J. L., McNeish, J. D., & Reynolds, L. S. (2005) · Journal of Biological Rhythms · doi:10.1177/0748730404273432 · Cited by 50
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype
Galeotti, N., Bartolini, A., & Ghelardini, C. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.12.016 · Cited by 50
Melanin concentrating hormone increase hippocampal synaptic transmission in the rat
Varas, M., Pérez, M. F., Ramı́rez, O., & de Barioglio, S. R. (2002) · Peptides · doi:10.1016/s0196-9781(01)00591-5 · Cited by 50
Terry, A. V., Buccafusco, J. J., & Bartoszyk, G. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2114-1 · Cited by 50
Piggins, H. D., Samuels, R. E., Coogan, A. N., & Cutler, D. J. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1301 · Cited by 50
Treatment of Refractory Major Depression With Tramadol Monotherapy
Shapira, N. A., Verduin, M. L., & DeGraw, J. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0312b · Cited by 50
Proerectile effects of apomorphine in mice
Rampin, O., Jérôme, N., & Suaudeau, C. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00122-x · Cited by 50
Grassi-Zucconi, G., Semprevivo, M., Mocaër, E., Kristensson, K., & Bentivoglio, M. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02032-2 · Cited by 50
D1 Agonist Dihydrexidine Releases Acetylcholine and Improves Cognitive Performance in Rats
Steele, T., Hodges, D. B., Levesque, T. R., & Locke, K. W. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00290-6 · Cited by 50
Mallinckrodt, C. H., Raskin, J., Wohlreich, M. M., Watkin, J. G., & Detke, M. J. (2004) · BMC Psychiatry · doi:10.1186/1471-244x-4-26 · Cited by 50
Castanon, N., Medina, C. F., Mormède, C., & Dantzer, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00142-2 · Cited by 50
Dopamine D5 receptor modulates male and female sexual behavior in mice
Kudwa, A. E., Domínguez-Salazar, E., Cabrera, D. M., Sibley, D. R., & Rissman, E. F. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2150-5 · Cited by 50
Modifiable neuronal connections: an overview for psychiatrists
Jeffery, K. J., & Reid, I. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.156 · Cited by 50
Long-term effectiveness of cognitive therapy in major depressive disorder
Hensley, P. L., Nadiga, D., & Uhlenhuth, E. H. (2004) · Depression and Anxiety · doi:10.1002/da.20022 · Cited by 49
Total sleep deprivation decreases immobility in the forced-swim test
Lopez-Rodriguez, F., Kim, J., & Poland, R. E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300406 · Cited by 49
Depression in schizophrenia: I. association with neuropsychological deficits
Kohler, C. G., Gur, R. C., Swanson, C. L., Petty, R. G., & Gur, R. E. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00033-4 · Cited by 49
Priest, C. A., Vink, K. L., & Micevych, P. E. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00184-g · Cited by 49
Schofield, G. G., Witkop, B., Warnick, J. E., & Albuquerque, E. X. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.5240 · Cited by 49
Szuba, M. P., O’Reardon, J. P., & Evans, D. L. (2000) · Depression and Anxiety · doi:10.1002/1520-6394(2000)12:3<170::aid-da9>3.0.co;2-m · Cited by 49
Stein, D. J., Kasper, S. F., Andersen, E. W., Nil, R., & LADER, M. H. (2004) · Depression and Anxiety · doi:10.1002/da.20043 · Cited by 49
How receptor mosaics decode transmitter signals. Possible relevance of cooperativity
Agnati, L. F., Fuxé, K., & Ferré, S. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.02.010 · Cited by 49
Pindolol Augmentation in Depressed Patients Resistant to Selective Serotonin Reuptake Inhibitors
Perry, E. B., Berman, R., Sanacora, G., Anand, A., Lynch-Colonese, K., & Charney, D. S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0215 · Cited by 49
Pomeratz, S. M., Hepner, B. C., & Wertz, J. M. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90179-l · Cited by 49
Ferszt, R., Kühl, K.-P., Bode, L., Severus, E., Winzer, B., Berghöfer, A., Beelitz, G., Brodhun, B., Müller-Oerlinghausen, B., & Ludwig, H. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979220 · Cited by 49
Imaging genetic influences in human brain function
Mattay, V. S., & Goldberg, T. E. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.03.014 · Cited by 49
Dam, J., Ryde, L., Svejsø, J., Lauge, N., Lauritsen, B. J., & Bech, P. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979298 · Cited by 49
Nakagawa, Y., Ishima, T., Ishibashi, Y., Yoshii, T., & Takashima, T. (1996) · Brain Research · doi:10.1016/0006-8993(95)01273-7 · Cited by 49
Aizenberg, D., Gur, S., Zemishlany, Z., Granek, M., Jeczmien, P., & Weizman, A. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199706000-00004 · Cited by 49
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.